ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.00
1.57%
Dow Jones
38,239.66
0.40%
Brent Oil
88.165
0.00%
Bitcoin
63,214.95
-0.82%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Cartesian Therapeutics Inc (RNAC) Quote

Cartesian Therapeutics Inc

Cartesian Therapeutics Inc (RNAC)

NASDAQ
21.03
0.13
(0.62%)
Closed April 27 4:00PM
Delayed by 15 minutes
21.10
0.07
(0.33%)
After Hours: 7:59PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
21.03
Bid
19.25
Ask
21.79
Volume
123,840
20.71 Day's Range 21.74
11.665 52 Week Range 42.60
Market Cap
3.417B
Previous Close
20.90
Open
20.90
Last Trade
3
@
21.5
Last Trade Time
Financial Volume
$ 2,625,490
VWAP
21.2007
Average Volume (3m)
560,253
Shares Outstanding
161,948,618
Dividend Yield
-
PE Ratio
-15.55
Earnings Per Share (EPS)
-1.36
Revenue
26M
Net Profit
-219.71M

About Cartesian Therapeutics Inc

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL... Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.selectabio.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Cartesian Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RNAC. The last closing price for Cartesian Therapeutics was $20.90. Over the last year, Cartesian Therapeutics shares have traded in a share price range of $ 11.665 to $ 42.60.

Cartesian Therapeutics currently has 161,948,618 shares outstanding. The market capitalization of Cartesian Therapeutics is $3.42 billion. Cartesian Therapeutics has a price to earnings ratio (PE ratio) of -15.55.

RNAC Latest News

More News

Cartesian Therapeutics to Present at the ASGCT 27th Annual Meeting

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that recently reported...

April 22 2024
Business Wire

Cartesian Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that its management...

April 04 2024
Business Wire

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company developing mRNA cell therapies for the treatment of autoimmune diseases, today announced the...

April 04 2024
Business Wire

Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock Split

GAITHERSBURG, Md., March 28, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for...

March 28 2024
GlobeNewswire Inc.

Cartesian Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

Topline data from Phase 2b study of Descartes-08, the Company’s potential first-in-class mRNA CAR-T cell therapy, in myasthenia gravis (MG) remains on track for mid-2024 On track to initiate...

March 07 2024
GlobeNewswire Inc.

Cartesian Therapeutics to Participate in Upcoming Investor Conferences

GAITHERSBURG, Md., March 06, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for...

March 06 2024
GlobeNewswire Inc.

Cartesian Therapeutics Announces New Employment Inducement Grant

GAITHERSBURG, Md., March 05, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company developing mRNA cell therapies for the...

March 05 2024
GlobeNewswire Inc.

Cartesian Therapeutics Establishes New Corporate Headquarters and State-of-the-Art mRNA Cell Therapy cGMP Manufacturing Facility in Frederick, Maryland

New facility expected to support expanded cGMP manufacturing of clinical and commercial supply of Company’s pipeline of mRNA cell therapies for the treatment of autoimmune diseases GAITHERSBURG...

March 05 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
13.9523.126463700217.0821.7416.98510675319.99032524CS
41.537.8461538461519.521.7411.66533952316.09935158CS
12-0.642-2.9623477297921.67224.1511.66556025319.3594623CS
26-3.165-13.081215127124.19542.611.66574611923.41872539CS
52-3.165-13.081215127124.19542.611.66574611923.41872539CS
156-3.165-13.081215127124.19542.611.66574611923.41872539CS
260-3.165-13.081215127124.19542.611.66574611923.41872539CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

Discussion

View Full Feed
tr8dervic tr8dervic 52 seconds ago
Mega Million numbers for 04/26/2024 are:

15 23 53 57 61 Mega Ball 09
Megaplier is 3

There was no Jackpot Winner

The estimated Jackpot was $228.0 Million ( $102.5 Million cash).

The next drawing is on Tuesday, Apr 30, 2024 w
lodas lodas 1 minute ago
If WAMU, or WMI was harmed by LIBOR, the why didn't they institute the lawsuit instead of the FDIC?....the reason is WAMU,WMI did not have a case, or was harmed, but the FDIC was in insuring the Liabilities of WAMU Banks which they were not being paid for !!!!! duhhhh.....so, since the FDIC does not
COOP
mick mick 1 minute ago
PROBABLY TRUE
Eli's Gone Eli's Gone 2 minutes ago
GL...
kund kund 2 minutes ago
I still believe in Anavex science, but the FDA corruption is a bit concerning. you are bullish on science which has not proved anything in last 10 year but keep blaming FDA for not approving drug. Have you seen FDA approving drug without filing NDA and data?

Clown knows something whic
AVXL
Bright Boy Bright Boy 3 minutes ago
Would anyone on this board, especially EX and LC2020 like to venture a guess as to what the current market is for financing small companies that use common stock as the centerpiece of the deal?????



Cheers,

BB
NWBO
Probity Probity 3 minutes ago
“For some reason some get their kicks by making things more complicated than they actually are.”

There’s always some reason gg. Sometimes by design.

imo
BIEL
mick mick 3 minutes ago
LANDSCAPING ????? WOW. THANX
FCGD
WOOFERHEAD WOOFERHEAD 4 minutes ago
Meant to put a correction up.

https://www.otcmarkets.com/filing/html?id=16645579&guid=kgQ-kW1ZyV12dth

Entry into a Material Definitive Agreement.


On May 5, 2023, BioPower Operations Corporation, a Nevada corporation (the “Company,” “we,” “us,”
BOPO
blackhawks blackhawks 4 minutes ago
Now that's some 'drilling down' by you. I just presumed......donald trump holds campaign rally in support of arizona gop candidates....is from a few years ago.

As far as the picture, looks like the same thick necked double chinned guy we usually see. Though it does reveal more baldnes
fuzzy fuzzy 5 minutes ago
9-19-6-8....tia
I-Glow I-Glow 5 minutes ago
The more dollar signs the less credibility the pumper has - Park is a serial scammer and the press release is for pumping purposes only.

"HUGE News if this doesn’t go to a Dollar I’ll eat my hat. $$$$$$$$$$$$$"

If anyone believes the press release they deserve to lose t
SPZI
docsetc docsetc 6 minutes ago
I had Legal Zoom do my incorporation and registration as a Texas Business. That cost me all of $900.00. I pay $250.00 per year for the Legal Zoom team to act as my registered agent for my S-Corp status in Texas to keep me current.

It can be done cheap and fast, from any state.
ENZC
kenman1 kenman1 6 minutes ago
Sounds good BigMoneyChalupa👋🏽
GVSI
nowwhat2 nowwhat2 7 minutes ago
Chinas' ETF's starting off around 62,000 (and / or even around THESE levels), would give them a fairly nice start.....
If their response to them is "tepid" (which doesn't seem likely), then this decline's got quite a long ways to go still.


https://investorshub.advfn.co
BTCUSD
trader59 trader59 8 minutes ago
It wasn’t faked. That’s just another con artist pumper lie. The amendment was submitted by the company to the NVSOS and it also included the name change.
IGPK
highlandernew highlandernew 8 minutes ago
🔴🔴AMC now ¢0.32 cents aka 12.8x: *not* MOASS?!: https://investorshub.advfn.com/uimage/uploads/2024/4/22/hjhqjAMC_APEX2.png

https://investorshub.advfn.com/uimage/uploads/2024/4/22/hjhqjAMC_APEX2.png

https://investorshub.advfn.com/uimage/uploads/2024/4/15/
AMC
payupdeadbeat payupdeadbeat 8 minutes ago
Lp, Make the corrupt bashers eat crow. But if you can, make it happen for breakfast on Monday.
DBMM
VVVVVV VVVVVV 8 minutes ago
Hopefully, you’re right.

Still a little more on the downside then as we get closer to July we should see the PPS increase more. But, not as much as it should if VPLM were more transparent with the market!

IMHO
VPLM
WOOFERHEAD WOOFERHEAD 9 minutes ago
BOPO SECURITY DETAILS UPDATED 4-26-2024

https://www.otcmarkets.com/stock/BOPO/security

https://www.youtube.com/watch?v=KQMHaf3RTgs

Cheers!

$BOPO BOPO $BOPO
BOPO
pos_stock_hoarder pos_stock_hoarder 9 minutes ago
Front page news. Well, page 2. Framing Trump stays on page 1!
Johnniegalan Johnniegalan 9 minutes ago
exwan…i need clarification…are you saying that the EU patent is for the “reduce-it” (heart) indication and therefore the coast is clear (i.e. the patent Wall is sound)?
AMRN
stockwatcher1970 stockwatcher1970 9 minutes ago
That makes sense. Does that mean the merger has been finalized, or can they issue before SEC approval?
CRTG

Your Recent History

NASDAQ
RNAC
Cartesian Therapeutics
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved